(SLQT) Selectquote - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8163073005

SLQT: Insurance, Medicare, Life, Auto, Home, Prescription, Pharmacy

SelectQuote, Inc. (NYSE:SLQT) is a technology-driven, direct-to-consumer insurance platform that leverages its digital capabilities to distribute a wide range of insurance products and healthcare services across the United States. The company operates through four distinct segments: Senior, Healthcare Services, Life, and Auto & Home. This diversification allows SelectQuote to cater to various customer needs, enhancing its market reach and revenue streams.

In the Senior segment, SelectQuote specializes in Medicare-related products, offering Medicare Advantage, Medicare Supplement, and Medicare Part D plans. Additionally, they provide ancillary products such as prescription drug coverage, dental, vision, and hearing plans. This focus on the senior demographic is strategic, given the aging U.S. population and the increasing demand for healthcare services.

The Life segment includes term life, final expense, and other ancillary products like critical illness and accidental death insurance. These offerings are designed to meet the needs of a broad demographic, from young families to retirees, ensuring that SelectQuote remains a one-stop solution for life insurance needs.

The Auto & Home segment offers a variety of property and casualty insurance products, including homeowners, auto, and dwelling fire insurance. This segment targets a stable market, as these insurance products are essential for most households, providing a consistent revenue stream for the company.

Beyond insurance, SelectQuote provides additional services such as SelectRx, a patient-centered pharmacy that offers essential medications, over-the-counter drugs, and medication management services. This adds value to their healthcare offerings, improving customer retention and potentially increasing revenue through ancillary services.

From a financial perspective, SelectQuote has a market capitalization of approximately $1.017 billion, with a price-to-sales (P/S) ratio of 0.74 and a price-to-book (P/B) ratio of 3.12. The forward price-to-earnings (P/E) ratio is 66.67, indicating expectations for significant growth. These metrics suggest that SelectQuote is valued at a reasonable multiple of its sales, with room for expansion in earnings.

SelectQuotes diversified revenue streams and recurring business model make it an attractive investment opportunity. The companys ability to leverage technology to enhance customer experience and streamline operations positions it well in the competitive insurance landscape. Investors looking for exposure to the insurance sector, particularly in segments with stable demand, may find SelectQuotes business model compelling.

Additional Sources for SLQT Stock

SLQT Stock Overview

Market Cap in USD 1,017m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Property & Casualty Insurance
IPO / Inception 2020-05-21

SLQT Stock Ratings

Growth 5y -58.0%
Fundamental -7.09%
Dividend 0.0%
Rel. Strength Industry 116
Analysts 4.33/5
Fair Price Momentum 3.94 USD
Fair Price DCF 0.44 USD

SLQT Dividends

No Dividends Paid

SLQT Growth Ratios

Growth Correlation 3m 94.8%
Growth Correlation 12m 61.5%
Growth Correlation 5y -64.3%
CAGR 5y -31.14%
CAGR/Max DD 5y -0.32
Sharpe Ratio 12m 1.57
Alpha 152.25
Beta 1.88
Volatility 116.71%
Current Volume 3539.4k
Average Volume 20d 3108.3k
What is the price of SLQT stocks?
As of February 23, 2025, the stock is trading at USD 4.57 with a total of 3,539,393 shares traded.
Over the past week, the price has changed by -23.83%, over one month by +3.16%, over three months by +75.10% and over the past year by +180.37%.
Is Selectquote a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Selectquote is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.09 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLQT as of February 2025 is 3.94. This means that SLQT is currently overvalued and has a potential downside of -13.79%.
Is SLQT a buy, sell or hold?
Selectquote has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy SLQT.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SLQT stock price target?
According to ValueRays Forecast Model, SLQT Selectquote will be worth about 4.7 in February 2026. The stock is currently trading at 4.57. This means that the stock has a potential upside of +3.5%.
Issuer Forecast Upside
Wallstreet Target Price 7.3 60.4%
Analysts Target Price 4.5 -1.5%
ValueRay Target Price 4.7 3.5%